Porsche Shares Slump as Company Faces Major

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
293
Porsche Shares Slump as Company Faces Major Headwinds

Porsche just got hammered by investors after admitting what everyone already suspected: betting big on electric vehicles while your customers still want gas-powered sports cars is a recipe for financial disaster. The German luxury carmaker’s shares tanked over 7% on Monday after the company slashed its profit margin guidance from a respectable 5-7% down to 2% for 2025, basically admitting they completely misread the market.

The whole mess stems from Porsche trying to force an electric transition on customers who aren’t buying it, literally. Rising U.S. tariffs, weaker demand, and China’s economic slowdown have created a perfect storm that’s forcing the company to backtrack on its EV rollout and extend the life of its combustion engines. Parent company Volkswagen is taking an even bigger beating, with a massive $6 billion hit from this product overhaul mess.

VW shares dropped 7.5%, heading for their biggest slide since 2023, which tells you everything about how confident investors are in this “strategic realignment.” The delays will slash Porsche’s operating profit by up to $2.1 billion this year, which is a huge chunk of change even for a luxury brand like Porsche. When Porsche went public three years ago, they were targeting over 20% return on sales in the long term.

Now they’re talking about maybe hitting 10-15% in the medium term, a clear sign that the luxury automaker miscalculated its EV transition timeline. Porsche shares have lost almost half their value since listing, proving that all those billions invested in electric vehicle development still haven’t produced anything that can seriously compete with Tesla or Chinese giants like BYD.

The broader issue is that European automakers are getting crushed between Chinese competitors offering cheaper EVs and American companies like Tesla that have an extended history of building popular and best selling battery electric vehicles.

While Porsche’s luxury positioning should have protected them from price wars, apparently even wealthy customers aren’t interested in electric sports cars that compromise on performance or driving experience. One stock trader summed it up perfectly, calling the company’s EV dependence a “mistake” that will take time and money to fix.

The fact that this is Porsche’s third profit warning revision this year shows they’re still figuring out how bad the situation really is. Some analysts think this might be the last revision, but given how Porsche seems to have mishandled the EV transition, that’s probably overly optimistic.

The EU’s 2035 ban on combustion engines is still looming, but auto executives are desperately lobbying Brussels to relax those targets because they’ve realized the transition timeline was completely unrealistic. For Porsche, this means trying to give customers the flexibility and drivetrain choices they actually want instead of forcing them into electric cars before they are ready or willing.

For startups like Bollinger Innovations, Inc. (NASDAQ: BINI) that specialize in producing BEVs, the choices on the way forward are relatively easier to make since they aren’t being compelled to change from making gas-powered vehicles to EVs.

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Mullen Automotive Inc. (MULN) Stock Research Links

MULN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Innovative Female Crash Test Dummy Design to Enhance Safety

Updated Category News Views 190

National Safety Council Embraces New Crash Test Dummy Design The National Safety Council is excited about the recent efforts by the U.S. Department of Transportation to introduce a new crash test dummy design tailored specifically for women. This initiative is a significant stride in addressing the troubling trend of higher injury and fatality rates experienced by women...

Continue Reading
Empowering Women: Hines Health Services Champions Equality

Updated Category News Views 166

Empowering Women in Healthcare at Hines Health Services On International Women's Day, Hines Health Services (HHS) proudly recognizes and honors the invaluable contributions of women in the workforce, particularly within the healthcare sector. This female-led organization, where women comprise 75% of the workforce, is dedicated to fostering a culture rooted in diversity,...

Continue Reading
James Hardie Industries Faces Securities Investigation; What You Need to Know

Updated Category News Views 122

Understanding the Investigation of James Hardie Industries James Hardie Industries plc, noted for its specialized construction materials, is currently facing scrutiny regarding its business practices, particularly in relation to its sales reporting. This investigation raises critical questions for current and prospective investors about the integrity of the company's...

Continue Reading
Chapters Health System Revamps National Grief Support Initiatives

Updated Category News Views 49

Transforming Grief Support for Children Chapters Health System has taken significant steps in rebranding its grief support camps for children under a unified name and logo: Camp Brave Heart. This initiative is set to launch in 2026, reflecting the organization's dedication to providing a nurturing and supportive environment for children experiencing the loss of a loved...

Continue Reading
Enhancing Trial Participation: ProofPilot and Inspire Join Forces

Updated Category News Views 121

Enhancing Trial Participation with Innovative Partnerships In a remarkable collaboration, ProofPilot, a pioneer in Clinical Experience Platforms (CXP), has teamed up with Inspire, an esteemed online health community dedicated to patient engagement. This partnership is set to revolutionize the way patients connect with clinical trials, ultimately enhancing recruitment...

Continue Reading